PDAC early diagnosis
early diagnosis of pancreatic cancer
Ab-EZR
early detection of pancreatic cancer
novel biomarkers EZR
Ab-ENOA
EZR kit
Feasibility study
correct diagnosis of PDAC
general diagnosis of PDAC
specific markers of early stage pancreatic cancer
development stage
Te study
leading cause of cancer
therapeutic assessment
Pancreatic Ductal AdenoCarcinoma
validation
feasibility report
industrial development
antibodies
Blood positivity
CA19
risk
huge market
potential market
invasive diagnostic screening
immunodiagnostic kits
field of IVD
IVD segment
combined use of blood test
screening of population
industrialization process
robust tool
key player
key components
final technological target of Natimab project
unmet medical need
CLIA formats
GeNeuro
great importance
ELISA
Ezrin
CE marking
consolidated distribution network
phosphorilated alpha-Enolase isoforms
production
introduced company
developed world
detailed business plan
related death
mover
people
marker panel
technical capabilities
companies
Iris Biotech
treatment
ambition
sensitivity
expert
assays
specificity
deliverable